Condition: Early Alzheimer's Disease · Sponsor: Eisai Inc.
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiority of lecanemab compared with placebo on the change from baseline in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) at 18 months of treatment in the Core Study. This study will also evaluate the long-term safety and tolerability of lecanemab in participants with EAD in the Extension Phase and whether the long-term effects of lecanemab as measured by the CDR-SB at the end of the Core Study is maintained over time in the Extension Phase. Extension Phase Part B will continue dosing with lecanemab in countries where lecanemab may not be commercially available.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Banner Alzheimer's Institute- Clinical Trials Department | Phoenix, Arizona, United States | — |
| Banner Sun Health Research | Sun City, Arizona, United States | — |
| Neurological Associates of Tucson dba Center for Neurosciences | Tucson, Arizona, United States | — |
| Neurology Center of North Orange County | Fullerton, California, United States | — |
| Irvine Clinical Research | Irvine, California, United States | — |
| University of California - Los Angeles | Los Angeles, California, United States | — |
| Pacific Neuroscience Medical Group | Oxnard, California, United States | — |
| Stanford University Medical Center | Palo Alto, California, United States | — |
| Pacific Research Network, Inc | San Diego, California, United States | — |
| Sharp Mesa Vista Hospital | San Diego, California, United States | — |
| UCSF Memory and Aging Center | San Francisco, California, United States | — |
| Apex Research Institute | Santa Ana, California, United States | — |
+ 235 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.